Advisory Board and Editors Biochemistry
Camillo Rosano
A physicist; in 1996 Camillo Rosano started his studies in Macromolecular Crystallography at the Advanced Biotechnology Center, Genova (I). In 1997 he achieved the Advanced Certificate in Principles of Protein Structures (PPS), Birkbeck College, University of London, UK, and in 1998 he spent a period at the “York Structural Biology Laboratory” York University, York, UK for a Macromolecular crystallography traineeship. He participated to the NASA expeditions STS100/ISS6A and STS110/ISS7A by designing experiment of protein crystallization on-board the International Space Station (ISS). Director of different Courses and Workshops, he is the author/coauthor of more than 100 peer-reviewed scientific publications.
Dr. Rosano is a Full Professor in Biochemistry and Full Professor in Applied Biology. Italian Ministry for University, Education and Research (MIUR), 2012.
Michael G. Rossmann
The Hanley Distinguished Professor of Biological Sciences, Purdue Univ; Member of the Nat. Academy of Sciences; Foreign Member of the Royal Society of London; Fellow of the American Association for the Advancement of Science; Past Member of the National Science Board. Awards include the Paul Ehrlich & Ludwig Darmstaedter Prize; the Fankuchen Award; the Louisa Gross Horwitz Prize; the Gregori Aminoff Prize; the Stein and Moore Award; the Ewald Prize; the Elisabeth Roberts Cole Award.
Ulrika Rova
Besides current research activities in pre-treatment and biochemical conversion of lignocellulose Rova has a background in recombinant protein expression, protein crystallization, biochemical characterization of catalytical properties of enzymes.
Rob Russell
Co-director of Bioquant and Professor of Protein Evolution at Heidelberg University. Previously Group Leader at EMBL, Heidelberg, Academic Editor at FEBS Letters at PLoS Computational Biology.
Michael F Santillo
I have over a decade of experience leading independent laboratory research projects as a research chemist at the U.S. Food and Drug Administration (FDA). The focus of my work is using in silico (computational tools, especially QSAR) and in vitro (cellular and biochemical) methods for identifying chemical hazards associated with foods and dietary supplements.
Darren N Saunders
Senior Lecturer in Medicine at the University of NSW and visiting fellow at the Kinghorn Cancer Centre, Garvan Institute in Sydney, Australia. Science communicator and past deputy chair of the Australian Academy of Science Early-Mid Career Researcher Forum. Australian Leadership Award (2012), NSW Life Scientist Research Award (2010).
My research is focused on proteostasis and metabolic reprogramming in cancer and neurodegeneration, integrating various platforms (including proteomics, genomics, and metabolomics) to better understand genotype-phenotype relationships. I have a long-standing interest in protein homeostasis (proteostasis), publishing numerous manuscripts providing mechanistic insights into serpin biology and the Ubiquitin-proteasome system, with more recent work aimed at characterising novel mutations involved in protein misfolding and Ub systems in various disease states. I developed a novel platform for screening protein-protein interactions in situ, and novel proteomics approaches to systematically identify E3 Ub ligase substrates and for exploring interactome diversity in cell signalling. We use a number of models systems including patient-derived iPS cells, patient derived tumour xenografts and transgenic models of cancer and neurodegeneration. I am also collaborating to develop creative technology-based approaches to visualizing and communicating complex data, using music to explore the intersection between genetics and environment.
Primo Schär
PhD University of Berne, Switzerland with Prof. J. Kohli; Research focus: Yeast genetics, mechanisms of meiotic recombination.
Postdoctoral fellow at the University of Berne, Switzerland with Prof. J. Kohli; Research focus: Yeast genetics and DNA Mismatch Repair in Meiotic Recombination.
Postdoctoral fellow at the Imperial Cancer Research Fund (Cancer Research UK), London UK, with Prof. Tomas Lindahl; Research focus: Function of DNA ligases in yeast and mammalian DNA repair, DNA base excision repair.
Junior research group leader at the Institute of Molecular Cancer Research, University of Zürich, Switzerland; Research focus: Genome Stability, DNA double strand-break repair and DNA base excision repair in yeast and mammalian cells.
Since 2003 Professor and research group leader at the Department of Biomedicine, University of Basel, Switzerland; Research focus: Molecular mechanisms underlying (Epi)Genome plasticity in stem cells, DNA base excision repair in DNA demethylation and cell fate programming.
Martina Schroeder
Dr Martina Schroeder is a Lecturer and Head of the Host-Pathogen Interaction Lab at Maynooth University. Her research addresses viral recognition, innate immune signaling pathways, and the roles of DEAD-box proteins in immunity. Previously Dr Schroeder conducted postdoctoral research with Prof. Andrew Bowie at Trinity College Dublin. In 2007, she was awarded a postdoctoral career development fellowship by the Irish HRB. She completed her PhD at the Charité University Hospital in Berlin in 2003.
Mirela Sedic
Dr Mirela Sedic (born Bauman) is Principal Scientist at the Institute for Anthropological Research Zagreb. She has authored over 50 scientific publications in peer-reviewed journals including high-impact journals such as BBA Molecular Basis of Disease, Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Cancer Treatment Reviews.
She was the co-PI of international collaborative project with Functional Genomics Center Zurich in Switzerland (PRIME-XS-0000184 Proteomic profiling of retinal proteins from rat model of age-related macular degeneration 2012-2014) and the PI of the University of Rijeka grant “Screening and biological evaluation of acid ceramidase and sphingosine kinase inhibitors as a new class of anti-tumour agents” (2014 – 2017). She is currently the PI of the project funded by the Croatian Science Foundation “Dissecting the mechanisms of therapy resistance in BRAF-mutant colon cancer using an integrated –omics approach” (2019 – 2023) and the PI of the University of Rijeka research grant “Molecular features associated with BRAFV600E-mutated versus wild type BRAF colorectal cancer” (2019-2022). She is also the PI of the project No. 3238 - EPIC-XS 012: “Proteomic analysis of acquired resistance to vemurafenib in BRAF V600E–mutant colon cancer cells” (2019 - 2022) in collaboration with the Functional Genomics Center Zurich in Switzerland.
Katsuhiko Shirahige
Professor, Laboratory of Genome Structure and Function, Institute of Molecular and Cellular Biosciences, The University of Tokyo.
Director of Research Center for Epigenetic Disease, The University of Tokyo
Jerson L. Silva
Professor of Biochemistry in the Institute of Medical Biochemistry at Universidade Federal do Rio de Janeiro. Awards include Fellow of the John Simon Guggenheim Foundation, TWAS Prize in Biology. Member of the Brazilian Academy of Sciences; the National Academy of Medicine; and Fellow of the Academy of Sciences for the Developing World (TWAS). Director of the Jiri Jonas National Center for Nuclear Magnetic Resonance (UFRJ)
Alison J Sinclair
BSc in Biochemistry from UCL London UK; PhD Cancer Virology at the Imperial Cancer Research Fund, London UK; post-doctoral fellowship at the European Molecular Biology Laboratory in Heidelberg, Germany, researching transcription; post-doctoral fellowship and assistant member of staff at the Ludwig Institute for Cancer Research in London, investigating a transcription factor network in Epstein-Barr virus and cell cycle regulation. Faculty School of Life Sciences at the University of Sussex, UK.